PUNE, India, November 14, 2017 /PRNewswire/ --
Nerve Repair and Regeneration Market Size will reach $10.59 billion by 2022 from $5.79 billion in 2017 at a CAGR of 12.9% between (2017-2022) driven by the increasing number of neurological disorders, rising geriatric population, and technological advancements; while North America is expected to account for the largest regional segment in the market.
Browse 83 Market Data Tables and 31 Figures spread through 122 Pages and in-depth TOC on "Nerve Repair and Regeneration Market by Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy, Neurostimulation Surgery), Products (Biomaterials, Nerve Conduits, Nerve Protectors, Nerve Wraps, Neurostimulation Devices) - Global Forecast to 2022" http://www.reportsnreports.com/reports/267919-nerve-repair-regeneration-market-by-xenografts-conduits-protectors-neuromodulation-internal-spinal-cord-deep-brain-external-transcranial-magnetic-surgery-direct-nerve-repair-grafting-stem-cell-global-trend-forecast-to-2018.html
Key players operating in the nerve repair and regeneration market include Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), Liva Nova (UK), Baxter (US), AxoGen (US), and Stryker (US).
Geographically, the nerve repair and regeneration market is dominated by North America, followed by Europe. The North American region is estimated to account for the largest share in 2017 and the trend is expected to continue during the forecast period. The growth in this market can be attributed to the presence of major key players in the region and growing incidence of peripheral nerve injuries. On the other hand, donor-site morbidity, difficulties in treating large nerve gaps, and stringent regulatory frameworks and time-consuming approval processes may challenge the growth of the market.
Make an Inquiry on "Nerve Repair and Regeneration Market - Global Forecast to 2022" research report at http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=267919
Based on application, the nerve repair and regeneration market is segmented into into internal neurostimulation and neuromodulation surgeries and external neurostimulation and neuromo dulation surgeries. The internal neurostimulation and neuromodulation surgeries segment is expected to register highest growth rate during the forecast period. This growth can be attributed to its wide application in neurological disorders. This report will enable both established firms as well as new entrants/smaller firms gauge the pulse of the market, which in turn will help these firms garner greater market shares.
On the basis of product, the nerve repair and regeneration market is segmented into neurostimulation and neuromodulation devices and biomaterials. In 2017, the neurostimulation and neuromodulation devices segment is expected to account for the largest share of this market segment. This growth can be attributed to the increasing neurological disorders and favorable reimbursement policies. Firms purchasing the report can use any one or a combination of the five strategies mentioned below to strengthen their market shares.
Inquire for Discount on "Nerve Repair and Regeneration Market - Global Forecast to 2022" research report at http://www.reportsnreports.com/contacts/discount.aspx?name=267919
The primary interviews conducted for this report can be categorized as follows:
- By Company Type: Tier 1 - 35%, Tier 2 - 22% and Tier 3 - 43%
- By Designation: C level - 15%, Director level - 32%, Others - 53%
- By Region: North America - 32%, Europe - 27%, Asia - 22%, RoW - 19%
The report analyses the nerve repair and regeneration market by product, applications, end user, and regions. Apart from comprehensive geographic and market sizing, the report also provides the competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the report profiles companies with developments, and strategies adopted by key players to maintain and increase their shares in the market. The above-mentioned market research data, market size, and forecast of future trends will help key market players and new entrants to make the necessary decisions to be successful in the market.
Another research titled Stem Cell Therapy Market Global Forecasts to 2021 says, the global stem cell therapy market is estimated to grow at a CAGR of 11.0% during 2016 to 2021 to reach $145.8 million by 2021. The North American region is expected to command the largest share in the stem cell therapy market in 2016. Based on the type of therapy, the allogeneic stem cell therapy segment is estimated to command the larger share of the global stem cell therapy market in 2016. Companies such as Osiris Therapeutics, Inc. (U.S.), MEDIPOST Co., Ltd. (South Korea), Anterogen Co., Ltd. (South Korea), Pharmicell Co. Ltd. (South Korea) have been profiled in this 120 pages research report available at http://www.reportsnreports.com/reports/281584-stem-cell-therapy-market-by-treatment-mode-autologous-allogeneic-therapeutic-applications-cns-cvs-git-wound-healing-musculoskeletal-eye-immune-system-regulatory-landscape-pipeline-analysis-global-forecasts-to-2020.html
Explore more reports on Medical Devices Market at http://www.reportsnreports.com/market-research/medical-devices/
ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.
2nd Floor, Metropole Building,
Next to Inox Theatre,
Bund Garden Road, Pune - 411001.
+ 1 888 391 5441
Connect with Us: